Assessing the relationship between antigenicity and immunogenicity of human rabies vaccines when administered by intradermal route: Results of a metaanalysis

Human Vaccines

Volumn 6, Issue 7, 2010, Pages 562-565

  Sudarshan, Mysore Kalappa ^a   Bilagumba, Gangaboraiah ^a   Ravish, Haradanahalli Shankarappa ^a   Hanumanthappa, Doddabele ^a   Narayana, Ashwath ^a  

^a KEMPEGOWDA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Antigenicity; Immunogenicity; Intradermal route; Metaanalysis; Rabies vaccines

Indexed keywords

DIPLOID CELL VACCINE; NEUTRALIZING ANTIBODY; RABIES VACCINE; VIRUS ANTIGEN;

ANTIGENICITY; ARTICLE; ASSAY; CORRELATION COEFFICIENT; DRUG POTENCY; HUMAN; IMMUNIZATION; IMMUNOGENICITY; RABIES; SERODIAGNOSIS; ANIMAL; BLOOD; CLINICAL TRIAL (TOPIC); IMMUNOLOGY; INTRADERMAL DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; META ANALYSIS; METHODOLOGY; MOUSE; VACCINATION;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIGENS, VIRAL; CLINICAL TRIALS AS TOPIC; HUMANS; IMMUNIZATION, SECONDARY; INJECTIONS, INTRADERMAL; MICE; NEUTRALIZATION TESTS; RABIES VACCINES; VACCINATION;

EID: 77957005784     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: 10.4161/hv.6.7.11934     Document Type: Article

References (20)

1. World Health Organization. Rabies vaccines, WHO position paper, weekly epidemiological record 49/50 2007; 82:426.
2. Proposed new WHO rabies control guidelines (Highlights from the WHO consultation on human and dog rabies prevention and control, France, Oct. 2009). Asian Biomed 2009; 3:751-4.
3. Sudarshan MK, Mahendra BJ, Madhusudana SN, Ashwath Narayana DH, Sanjay TV, Gangaboraiah, et al. Assessing the relationship between antigenicity and immunogenicity of human rabies vaccines: Results of a metaanalysis. Hum Vaccin 2005; 1:187-90.
4. Beran J, Honegr K, Banzhoff A, Malerczyk C. Potency requirements of rabies vaccines administered intradermally using the Thai Red Cross regimen: investigation of the immunogenicity of serially diluted purified chick embryo cell rabies vaccine. Vaccine 2005; 23:3902-7. (Pubitemid 40726183)
5. Lang J, Hoa DQ, Gioi NV, Vien NC, Nguyen CV, Rouyrre N. Immunogenicity and safety of low dose intradermal rabies vaccine given during an Expanded Programme on immunization session in Vietnam: results of a comparative randomized trial. Trans R Soc Trop Med Hyg 1999; 93:208-13. (Pubitemid 29233864)
6. Fishbein DR, Pacer RE, Holmes DF, Ley AB, Yager P, Tong TC. Rabies post-exposure prophylaxis with human diploid cell rabies vaccine: a dose-response study. J Infect Dis 1987; 156:50-5.
7. Ambrozaitis A, Laiskonis A, Balciuniene L, Banzhoff A, Malerczyk C. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): An immunogenic, cost-effective and practical regimen. Vaccine 2006; 24:4116-21.
8. Charanasri U, Kingnate D, Meesomboon V, Samuthananon P, Chaeychomsri W. Intradermal simulated rabies post-exposure prophylaxis using purified chick embryo rabies vaccine. J Med Assoc Thai 1992; 75:639-42.
9. Ubol S, Phanuphak P. An effective economical intradermal regimen of human diploid cell rabies vaccination for post-exposure treatment. Clin Exp Immunol 1986; 63:491-7.
10. Suntharasamai P, Chaiprasithikul P, Wasi C, Supanaranond W, Auewarakul P, Chanthavanich P. A simplified and economical intradermal regimen of purified chick embryo cell rabies vaccine for post-exposure prophylaxis. Vaccine 1994; 12:508-12.
11. Madhusudana SN, Prem Anand N. Response to purified chick embryo cell rabies vaccine administered intra-dermally for post-exposure prophylaxis. The Nat Med J India 1997; 10:115-6.
12. Briggs DJ, Banzhoff A, Nicolay U, Sirikwin S, Dumavibhat B, Tongswas S. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified vero cell rabies vaccine. Bull World Health Organ 2000; 78:693-8.
13. Sudarshan MK, Madhusudana SN, Mahendra BJ, Ashwath Narayana DH, Ananda Giri MS, Popova O. Evaluation of a new five-injection, two-site, intradermal schedule for purified chick embryo cell rabies vaccine: A randomized, open-label, active-controlled trial in healthy adult volunteers in India. Current Therapeutic Res 2005; 66:323-34.
14. Madhusudana SN, Sanjay TV, Mahendra BJ, Sudarshan MK, Ashwath Narayana DH, Ananda Giri MS. Comparison of safety and immunogenicity of purified chick embryo cell rabies vaccine (PCEV) and purified vero cell rabies vaccine (PVRV) using the Thai Red Cross intradermal regimen at a dose of 0.1 ml. Hum Vaccin 2006; 2:200-4.
15. Wilde H, Khawplod P, Hemachudha T, Sitprija V. Postexposure treatment of rabies infection: can it be done without immunoglobulin? CID 2002; 34:477-80.
16. Madhusudana SN, Prem Anand N, Shamsundar R. Evaluation of two intradermal vaccination regimens using purified chick embryo cell vaccine for postexposure prophylaxis of rabies. Nat Med J India 2001; 14:145-7.
17. A report on "A clinical evaluation of safety and immunogenicity of purified chick embryo cell rabies vaccine (PCECV), administered intradermally using updated Thai Red Cross regimen in animal bite cases". 2007, Novartis Vaccines, India.
18. A report on "A comparative, multi center Phase III, randomized (1:1) double blind study to evaluate the safety and immunogenicity of PVRV (Indirab vs. reference vaccine) administered intradermally using simulated updated Thai Red cross regimen in healthy volunteers". 2009, Bharath Biotech International Ltd., Hyderabad, India.
19. A report on "A comparative phase III, randomized (1:1) single blind study to evaluate the safety and immunogenicity of rabies vaccines (Indirab vs. reference vaccine) reconstituted with 1 mL diluent each, administered intradermally using simulated post exposure updated Thai Red Cross regimen in healthy volunteers". 2009, Bharath Biotech International Ltd., Hyderabad, India.
20. th ed. Geneva: World Health Organization 1996.